Ev Ev vid id iden en ence ce ce, , Un n niv iv iver e sity of Alberta, Edmonton, A A Alb lb lberta; 3 Faculty of P Pha ha har rmaceutical Sciences, n Un Univ iv iver ersi si sity ty o o of f Br Br Brit it itis is ish h h Co Co Colu lu lumb mb mbia ia ia, Va V n nc nco ouv ve ver, r, r, B B Bri ri riti tish sh sh C C Col ol o u um umb bia, a, C C Can an anad ad ada a Background-Use of cardiovascular disease (CVD) risk calculators is often recommended by
Introduction
Cardiovascular disease (CVD) risk calculators assist clinicians in estimating a patient's risk of a cardiovascular event. These calculated risk estimates (RE) are often used to place patients into specific risk categories. This categorization is then used to guide intervention recommendations and/or determine the benefits of treatment. There are numerous CVD risk calculators (hereafter called calculators) with systematic reviews identifying 110 different risk-scoring methods 1 4, 5 or to each other, [6] [7] [8] and found that calculated RE are inconsistent between calculators.
Small variations in calculated RE between calculators are to be expected. However, as calculated RE variation increases, calculators will more frequently categorize the same patient into different risk categories. 7 In theory, this could lead clinicians to make different recommendations for their patients based solely on which calculator is used.
Previous studies, directly comparing how different calculators categorize patients, had only three calculators 7 or only one patient. 8 The largest to date, with 8 calculators, assessed agreement but provided limited information to compare how specific calculators agree in risk estimation or categorization. 6 A recent systematic review of CVD risk prediction models (calculators) concluded that more direct comparison of risk calculators was required. 9 The objective of this evaluation was to assess the consistency of a broad sample of commonly used calculators over a sample of patients with a range of cardiovascular risk factors.
overestimates risk in low-risk patients and underestimates risk in high-risk patien en nts. . . 3 3 So So Some me me tudies have compared Framingham to different calculators 4, 5 or to each other, [6] [7] [8] and found that ca alc lc cul ul ulat at ated ed ed R R RE E E ar re e e i in inconsistent between calculato o ors r r . .
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Methods

Calculator selection
Due to the large number of existing calculators, we decided to focus on a representative sample and so we selected calculators that: Were from a variety of countries; used Framingham and other databases; had a range of formats (internet, cell phone or PDA, paper & pencil, required triangulation on graph); were associated and not associated with guidelines; calculated risk over different durations (five-or 10-year risks); were with and without a diabetes category; and estimated different outcomes such as CVD or coronary heart disease (CHD). We excluded models that did not use age, gender, smoking status, blood pressure, total cholesterol and HDL or a cholesterol/HDL ratio to calculate risk. For example, we did not include models that substituted weight or BMI for lipid measurements or calculators on specific populations (e.g., Native
Americans).
We (FN, GMA and JM) initially searched PubMed and Google using the terms "cardiovascular risk calculators" or "heart disease risk calculators". We also scanned references of articles in this area. The purpose of the search was not to find all calculators but to locate a representative group of calculators. Once we had over 40 calculators meeting our inclusion criteria, we distributed the list to the clinician authors (FN, GMA, JM, CK, & MRK) who independently selected their top 20 calculators. Clinician authors were asked to select calculators they felt were commonly used and provided a broad representation of calculators.
This would include calculators from a variety of countries, some associated with common guidelines, different formats (internet, paper & pencil, required triangulation on graph); calculated risk over different durations (five-or 10-year risks) and outcomes (CVD or other);
and some with diabetes category. Votes by clinician authors were totaled and we included any a cholesterol/HDL ratio to calculate risk. For example, we did not include mode els ls s t tha ha h t t t su su subs bs bsti ti titu tuted m weight or BMI for lipid measurements or calculators on specific populations (e.g., Native
Am Am mer er eric ic ican an ns) s) s).
We (FN FN, , GM GM GMA A A a an and d d JM JM JM) ) in in nit it tia ia i l ll ly y sea ar rc ch hed d P Pu ubMe Me M d d an n nd d Go Go Goog gle le le u usi sing ng ng t t the he t t ter er rms ms ms "c car ar ardi di diov ov o as ascu cu cula lar r r r ris sk sk c cal alc cu cula l to to ors rs" " or or or " "h he ear ar art t t d d dise e eas as a e e e r ri risk k k c c cal al alc cu cula la ato to t rs rs r ". ". W We We a als ls so o o sc sc s an an nne ne ned r re refe fe f re re enc nc ces e r r r of articles in n t t thi hi his s ar ar area ea e . . T T The he e p p pur ur u po po pose se e o of f f th th the e e se se sear ar a ch ch ch w w was as a n n not ot o t t to o o fi fi find nd nd all ll ll c c ca a alc lc lcul ul ulat at a or or rs s bu bu but t t to to to locate a by guest on April 14, 2017 http://circ.ahajournals.org/ Downloaded from calculator recommended by three or more of the five clinician authors. Although only one of four calculators at the Edinburgh site were originally selected we included all 4 to allow for a direct comparison of the same website.
We performed one final search in July 2011 and identified a new review article 10 which included 21 calculators, three of which were previously unidentified and met our inclusion criteria. One of these calculators (Progetto CUORE) involved a different cohort and country, so it was also selected for inclusion.
Calculator inclusion and exclusion flow are presented in Figure 1 .
Patient Variables
Seven specific risk factors were used in all included calculators: age, gender, smoking status, blood pressure, diabetes, total cholesterol and HDL (or the ratio of the latter two). 13 The SCORE calculator had lowor high-risk country classification. We chose the high-risk classification as the majority of Seven specific risk factors were used in all included calculators: age, gender, smo mo oki ki ing ng g s sta ta tatu tu tus, s, s blood pressure, diabetes, total cholesterol and HDL (or the ratio of the latter two). To assess the va ari ri iab ab abil il ilit it ity y y of of of cal lcu cu cula lated RE among calculators fo fo for r a a a broad cohort t of o h hyp yp ypo o othetical patients, we assi i ign g ed two v val al alue e es fo fo for ea ea each ch ch o o of f th th he e e se sev ve ven n ri isk sk fac cto tors. T T The he tw wo wo v va al alue ues s fo o or r e ea eac ch ch r ris is isk k k fa fa f c ct c o or or w w wer er re:
ag age e e 70 70 70 o or r 50 50 50; ; ; ge gend nd nder er m m ma al ale e or r f fem em mal al ale e; e; c c cur ur rre re ren nt nt s s smo mo mok ki in ng g st t tat at atu us us y y yes es e o or r r no no n ; ; ; sy sy yst stol ol o ic ic ic b blo lo loo o od p p pre e ess ssu u ure e countries in SCORE were classified as high risk. Progetto CUORE did not allow input of age 70 so we used 69. For non-diabetics in the UKPDS risk calculator, we assigned an A1C of 5.2%
and zero for the duration of diabetes.
Calculation of Risk
For each calculator, two independent reviewers calculated RE on all 128 hypothetical patients. FN calculated RE with all calculators and the other four-clinician authors (GMA, JM, CK, MRK) completed six calculators each. Risks were compared and inter-rater agreement assessed.
When disagreement occurred, GMA and FN confirmed assessed risks again.
We then categorized the calculated RE for each hypothetical patient in to three-risk categories. The risk categories were selected to reflect the most common categorizations used for the calculators selected. Calculated risks from 10-year calculators (either CHD or CVD)
were categorized as low (<10%), moderate (10 to <20%), and high ( 20%). Calculated risks from five-year (CVD) calculators were categorized as low (<10%), moderate (10 to <15%) and high ( 15%). SCORE used only two risk categories, low (<5%) and high ( 5%).
Ethics approval was not required for this study (as patients were hypothetical).
Analysis
Sample calculations for each portion of the analysis are provided in Supplemental Material (Sample Calculations).
Variation in risk categorization
We defined concordance as the percent agreement in the risk category assignment in pairwise comparisons of two calculators. Although concordance is frequently reported using Kappa, we cal al alcu c cula la lat to tors rs w w wer ere e c c catego go orize ed ed as lo lo ow w (< (< <10 10%) %) %), mo mo od de era rat te te ( (10 10 0 t to o <1 <1 <15% % %) ) an an and hi high gh gh ( ( ( 15 15%) %) %). . SC SC CO OR ORE E E u us used e o o onl nl nly y y tw tw two o r ri risk sk sk c c ca a ate e ego go g r r rie es s, , lo lo l w w w (< (< (<5% 5% 5%) ) ) an an nd d d h h high gh gh ( ( 5% 5% %). ). ).
Ethics cs a a app pp ppro ro rova va val l wa wa as s s no no n t t re re requ qu uir i ed ed ed f f for or or t t thi hi his s st st stud ud udy y (a (a (as s pa pa pati ti ien en ents t w w wer er ere e e hy hy hypo po p th th thet et etic ic ical al al). ) ) comparisons.
We determined the number of patients assigned to the same category by all calculators.
For patients categorized into two or more risk categories by different calculators, we identified the maximum risk spread for each specific patient. For example, if a patient was categorized as low risk by one calculator and high risk by another, that patient had a three-risk category spread (low, moderate and high).
Variation in absolute risk calculation
For those calculators that provided absolute risk percentages for CVD or CHD over 10 years, we were able to assess the range in calculated RE for each patient. We evaluated the relative difference in calculated RE from different calculators by dividing the highest calculated RE by the lowest calculated RE for each patient.
Results
Characteristics of the 24 included unique calculators, 18 of which allowed for assessment of diabetics, are summarized in Table 1 All patients were run through each calculator by two authors. Agreement in risk calculated for each patient was 95% between authors. The 5% disagreement arose in three difference in calculated RE from different calculators by dividing the highest ca alc lc cul ul la ated ed ed R R RE E E by b by he lowest calculated RE for each patient.
R Res su sults
Ch Systematic errors, for example an author forgetting to change sex to female for a series of patients, caused another 2% decline in agreement. The remaining 1% decline resulted from singular or sporadic errors in data entry.
Variation in risk categorization
Overall, the 128 patients were categorized across a mean of 2.2 categories with 41% of patients crossing all three categories. Among diabetic patients, 25% were assigned to the same category by all calculators, 36% were assigned into two-risk categories and 39% were assigned across a three-risk category spread. For non-diabetics the assignment was 19%, 39% and 42%
respectively. Overall, 28 of 128 (22%) patients were assigned the same category by all calculators; 6 low risk, 0 moderate risk and 22 high risk.
The RE concordance (percent agreement in patients assigned the same risk category by a pair of calculators) for all calculators are available in Figures 2a and 2b. The average, median and range of the varying paired concordances for each calculator are available in Table 2 .
Progetto CUORE (code N) had the lowest average and median concordance in calculator pairs, <50% for non-diabetics and <40% for diabetics. JBS Risk Chart Assessment (G), QRisk2 2011 (I), and i-phone STAT ATP-III Lipid Management (X) and National Cholesterol Education
Program (Y) all had average and median concordances across calculator pairs of <60% for nondiabetics.
The pooled average concordance for all paired comparisons of non-diabetics was 64%, 73% for diabetics and 67% combined. Limiting the analysis to just 10 year CVD, to reduce the time variable (5 versus 10 year) and types of outcome variable, did not change the results in hree-risk category spread. For non-diabetics the assignment was 19%, 39% and d 42 42 42% % % espectively. Overall, 28 of 128 (22%) patients were assigned the same category by all ca alc lc cul ul ulat at ator or rs; s; s; 6 6 6 low ow w r r ris i k, 0 moderate risk and 22 h h hig ig igh h risk.
The RE RE c c con nco cord rdan an ance ce ce ( ( (p pe perc rc cen en nt t ag agreem m me e ent i in n pat ti tie en ents ts s a a ass ssig ig gn ne ed d th th the sa ame me me r ris isk k k c ca cate te ego go ory ry by y y a pa pair ir ir o o of f f ca calc lc cul ul ulat ator or rs) ) ) f for or r a a all ll c cal al lcu cula la lato to tor rs rs a a are re e a a av va vail l lab ab a l le e i i in n Fi Fi F gu gu gur r res s s 2a 2a 2a an an and d d 2 2 2b d d . . T T The he he a ave ve era ra rage ge e, m me med di dian an n and range of f t t the he he v v var ar aryi yi ying ng ng p pai ai aire re red d co co conc nc ncor or rda da danc nc nces es es f f for or or e e eac ac ch h ca ca calc lc cul ul ulat at ator or or are re re a a ava va vail il ilab ab able le e i i in n n T T Tab ab able 2.
clinically meaningful way. The pooled average concordance for pairs of 10 year CVD calculators only, was 68% for non-diabetics, 74% for diabetics, and 70% overall.
In order to further reduce variability, we performed post-hoc comparison of just those calculators that used the Framingham database (15 calculators -11 for diabetics). The pooled average concordance for pairs of Framingham-derived calculators was 68% for non-diabetics, 84% for diabetics, and 73% overall. Focusing further on the 9 Framingham derived 10 year CVD calculators (7 for diabetics), the pooled average concordance among pairs was 86% for non-diabetics, 93% for diabetics, and 89% overall. The pooled average concordance for pairs of European database derived calculators or the subgroup of 10-year CVD calculators from
European databases did not improve agreement (data not shown).
As an example of calculators recommended by national guidelines, Total CVD Risk (L)
from Canada had a 44% agreement with the National Cholesterol Education Program (Y) from the USA.
Variation between calculators in absolute risk calculation
We compared absolute calculated RE for the 10-year CVD and CHD calculators. The absolute difference in calculated RE (highest calculated RE minus the lowest calculated RE for each patient) was greater than the mean calculated RE in 78% of non-diabetics and 72% of diabetics.
In non-diabetics, the highest calculated RE was on average 4.9 times higher (range 1.9 to 13.3) than the lowest calculated RE for the same patient. In diabetics, the highest calculated RE was on average 5.2 times higher (range 1.8 to 11.7) than the lowest calculated RE.
Focusing on 10-year CVD calculators, the absolute difference in calculated RE was greater than the mean calculated RE in 55% of non-diabetics and 63% of diabetics. In nondiabetics, the highest calculated RE was on average 4.0 times higher (range 1.7 to 10) than the European databases did not improve agreement (data not shown).
As Va Va ari ri riat at atio io i n n be be betw twe ee een n n ca ca alc c cul ulat t tor or o s s s in in in a a abs bs sol ol lut ut ute e e ri ri risk sk s ca a alcu cu ula la ati ti tion on on
We compare ed d d ab ab abso so solu lu lute te e c c cal lcu cu cula la l te te ed d d RE RE RE f f for or o t t the he he 1 1 10-0-0 ye ye year ar ar C CVD VD VD a a and nd nd C C CHD HD HD c c cal al alcu cu cula la l to to ors rs rs. . Th Th The e absolute lowest calculated RE for the same patient. In diabetics, the highest calculated RE was 5 times higher (range 1.6 to 11.7) than the lowest calculated RE.
To show the distribution of calculated absolute RE from 10-year CVD and CHD calculators, a sample of ten patients with the absolute calculated RE is shown on Figure 3 . The ten patients chosen were distributed equally from highest to lowest risk determined by averaging the RE of all calculators for each patient and then ordering the patients by their average risk. 
Discussion
We used a total of 25 calculators to calculate CVD and CHD risks for 128 hypothetical patients.
Comparing concordance (agreement) in classification to three standard risk categories [low (<10%), moderate (10 to <20%), and high ( 20%)], pairs of calculators will assign a different category to the same patient approximately one third of the time. Despite attempts to remove variability by focusing on 10-year CVD calculators only, the concordance improved by only 2%.
The range in calculated RE for individual patients is likely clinically important, with the highest calculated RE being approximately 5 times higher than the lowest calculated RE on average.
Again, narrowing the calculators to just 10 year CVD did little to reduce this in a meaningful way.
In a post-hoc analysis, we found focusing on calculators using Framingham marginally calculated RE for Patient 9 is 11.2% (Edinburgh-ASSIGN) and 2.9% (Progetto C CU CUOR OR ORE) E) E), , fo fo for r a a ange in calculated RE of 8.3%.
D Disc c scussion
We We We u u use se sed d a a to to tota tal l of of of 2 25 5 ca ca alc lcul u at at ator r rs s s to to to c cal al lcu u ula la lat te te C C CVD VD VD a and nd d C C CH HD HD r r ris isk k ks s fo fo for r 12 2 28 8 hy hy hypo po poth th het et ti ica a al p p pat atie ie ent nt ts. s
Comparing co co onc nc ncor or orda da danc nc n e e e (a a agr gr gree ee e me me ment nt nt) ) in in n c c cla la lass ss ssif if ific ic i at at atio io ion n n to to o t thr hr hree ee ee s s st t tan a a da da dard rd rd r r ris is isk k k ca ca ate te tego go gori ri r es es e [low improved overall agreement from 67% to 73%. Often defined as non-fatal myocardial infarction and cardiac death, CHD is a subset of CVD and so it would be expected that calculated RE for CHD would be lower than calculated RE for CVD in the same patients. In our study, the calculated RE from CHD calculators was surprisingly frequently higher than many of the calculated RE from CVD calculators (see Figure   3 for examples). The inconsistency and variance found when 10 year CVD and CHD calculators were examined together did not change much when CVD calculators were examined alone.
Why CHD calculators are also so widely variable and frequently provide calculated RE in the range of CVD calculators is unclear.
We attempted to minimize some of the differences in focusing on 10-year CVD Framingham calculators. Although this is a relatively homogeneous group, agreement still only approached 90%. This may result from some calculators using more up to date versions of the endpoints (some include only hard endpoints, such as MI or stroke, while others s al a also so s i i inc nc nclu lu lude de de ofter endpoints such as angina and TIAs) and; mathematical algorithms that vary for the same da ata ta aba ba bas se se.
Often de defi f f n n ned d d as as n non on on-f -f -fa at atal al l m m myo yo oc ca ardi ia al infa a ar rc ction on on a an nd nd c car ardi diac ac d d de e eat th th, C C CH HD HD i i is a a a su su ubs bs bset et of f f CV CV VD D D an an a d d so so so i i it t w w wou ul uld d be be e e exp xpe ec e te te ted d d t t tha h hat t ca ca alc lc lcu u ulat at ated ed e R RE E f fo for r r CH CH CHD D D w w wou ou uld ld ld b b be lo low we wer r r th than an an cal al lcu u ula late te ed d d RE for CVD D i i in n n th th he e e sa sa s me me me p pat at a ie ie ient nt ts. s. s. In In In o o our ur u s s st t tud ud udy, y, y t t the he he c c cal alcu cu cula la late te ed d d RE RE RE f f fro ro rom m m t t t C C CHD HD H c c cal al alcu cu cula la ato t rs was m m m Framingham database. However, it is known that Framingham models require some recalibration for differing populations based on prevalence of risk factors and CHD rates. 16 Therefore, some of these differences may result from adjustments applied to the calculator algorithms to better reflect the population the risk calculators was designed for.
Most CVD guidelines encourage the use of CVD/CHD calculators and cross-sectional studies report that 22-48% of physicians regularly use risk assessment tools to determine CVD risk. [17] [18] [19] While the use of calculators appears to improve patients' perception of risk, 20 the effect on risk over time is small at best and there is no evidence for a reduction of actual CVD events. [20] [21] [22] Physician barriers to the implementation of risk calculation include time, a feeling that the information is not helpful, sense of oversimplification with risk tools, and an ability to predict risk subjectively. 17 While previous research has shown physicians struggle to subjectively estimate absolute risk accurately, they do appreciate patients' risks relative to a "normal" risk. 22 Another study found 60% of physicians' subjective estimations of patients' CVD risk category agreed with the Framingham risk score. 18 Compared to the Framingham risk equation, subjective estimations by physicians were as accurate in categorizing patients as four different calculators, 71% versus 66-81% respectively. 23 If clinicians are 60-71% accurate in subjective assessment of risk category (compared to a calculator) they may be as reliable as calculators, which agree 67% overall when using three risk categories.
Approximately 80% of primary prevention primary care patients have a calculated 5 year risk <10% (approximately <20% for 10 year risk). 24 Our study was designed to assess risk calculators over a broad range of risks. Our study has proportionally more high-risk patients and likely does not mirror a common primary care population. The variability in RE increased in hat the information is not helpful, sense of oversimplification with risk tools, an nd d d an an an a a abi bi bili li lity ty ty t to o predict risk subjectively. 17 Wh Wh Whil il ile e e pr rev ev evio ious research has shown phys s si ic icia a ans struggle to o s sub bje je ect ct ctiv i ely estimate absolute i i isk k k a accurately, y t t the he ey y do do d a a app pp ppre re reci c ciat ate e e p pa pat ti ien nts' ri is sks re rela a a ti i iv ve e t to o o a a a "n "n nor r rma mal" l" l" r ris isk. k. k. 22 22 22 An An not ot othe he h r st st stud ud udy fo oun un und d d 60 60 6 % % % of of of p ph h hys si sici cian ans' s' sub ub ubje je ject ct ctiv iv ive e es es sti ti ima ma mat t tion on ons s of of of p pa at atie ie ent nt nts s' C C CVD VD VD r r ris is i k k k c ca ate tego go g ry ry ry a a agr gr gree ed d d w wi with th h t th he he f f
Framingham m r r ris is isk k sc sc scor or ore. e. e 18 18 18 C C Com om ompa pa pare re r d d d to o o t t the he he F F Fra ra rami mi ming ng ngha ha h m m m ri ri risk sk sk e e equ qu quat a io io ion, n, n, s s sub ub ubje je ject ct tiv iv ive e e es es esti ti tima m tions by y higher risk patients, as shown in Figure 3 . However in patients with multiple risk factors, much of the RE variability occurred in risks above 20%. Therefore, although absolute risks can vary widely in higher risk patients, the risk category assigned by all calculators would be still be "High." Of the 28 patients assigned to a single risk category by all calculators, 22 (or 79%) were high risk. This is also supported by the slightly higher concordance among diabetics (compared to non-diabetics), as they are higher risk. Including patients with higher risks may have led to underestimation of the variability in assigned risk categories.
More research is required to understand the inconsistency in calculators. However, recommendations to use calculators should identify those that apply to the populations to be assessed and acknowledge the considerable inconsistency between them. For clinicians currently using calculators, it may be reasonable to use one calculator that best represents their patient population. The variability in the calculators identified in this study supports this approach. The risk calculator recommended for your community (typically by a guideline) uses a database that hopefully reflects typical practice in your area and hopefully has been calibrated to better account for any differences. Clinicians need to be aware however, that these calculators provide only ballpark estimates.
While a meta-analysis has shown overestimation in low-risk categories and underestimation in high-risk categories, 3 other data suggest general overestimation in primary care. 24 Our future work will attempt to identify calculators that consistently estimate low-or high-risk categories and those that are simply, consistently inconsistent.
Limitations
As described earlier, our study was designed to examine risk calculator variability across broad assessed and acknowledge the considerable inconsistency between them. For cl lin in nic ic cia ians ns n c c cur ur urre re r n ntly using calculators, it may be reasonable to use one calculator that best represents their patient po opu pu pula la lati ti tion on n. . Th T T e va va vari riability in the calculators iden en ent tif f fied in this stu udy dy d su upp pp ppor o ts this approach. The i i isk k k c calculator r re re eco o omm mm men en ende de ded d d fo f for r yo yo your ur u co o ommu mu munity y y ( (t typ p pic ic cal ally ly ly b b by y a a a g gu guid id del e e i in ne) e) ) u u use ses s a a a da da data ta aba ba ase se th h hat ho hope pe pefu fu full lly y y re re refl fl flec ect ts ts t t typ yp ypi ic ica al al p pra a act ct c ic ic ice e e in in in y you ou our r r ar ar area ea a a a and nd d h h hop op pef ef ful ul ull ly ly h h ha as s s be be been en e ca al alib ibr ra rate te ted d to to to b bet et tte er r account for an an ny y y di di iff ff ffer er e en en ence es. s. s. C C Cli i ini ni nici cian an a s s ne ne need ed ed t t to o o be be be a a awa wa w re re e h h how ow owev ev ever er e , th th that at at t t th h hes es ese e e ca ca calc lc lcul ul ulat at ator o s provide range of patient risk levels. However, our study may not mirror primary care populations and the variability in absolute RE may have been increased while the variation in risk category may have been reduced. Most of the "uncaptured" absolute RE variability in high-risk patients is unlikely to have much clinical relevance.
We did not review all available calculators. However, we have included more than any previous study and it is highly unlikely that adding more calculators would meaningfully change the inconsistency. It is quite possible that the purposeful heterogeneity of our risk calculator sample reduced the level of RE agreement. Removal of one or two variables did not seem to have important impacts on agreement. For example, concordance and variability changed little when CHD and CVD were analyzed together or when was CVD alone. However, we found by limiting the analysis further to 10 year CVD Framingham risk calculators brought agreement close to 90%. Therefore, it is quite possible that agreement between two calculators using the same database, endpoints and duration will have better agreement than the overall agreement from our sample of risk calculators.
We used hypothetical patients with dichotomized risk factors and it is possible that other values may have provided better consistency. However, hypothetical patients allowed for focal examination of the high and low values for each risk factor and representation of a broad range of patients. Additionally, our study supports other work done in this area [4] [5] [6] [7] [8] suggesting that the use of hypothetical patients did not bias the results.
Conclusion
Whether calculated risk estimates are used to assign categories and determine treatment cut-offs or are used to discuss risks and benefits with patients, the inconsistency between calculators when CHD and CVD were analyzed together or when was CVD alone. Howev ve e er, we we we f f fou ou ound nd nd b by y r imiting the analysis further to 10 year CVD Framingham risk calculators brought agreement cl los os se e e to to to 9 9 90% 0% 0%. . T The he here refore, it is quite possible that at t a ag gr reement betw wee ee e n tw tw wo o o calculators using the a am me me database, e e e end d dpo poin ints ts ts a a and nd nd d d dur urat at a io io i n n n w w will h h ha a ave b b be et tter r r a ag agre re ee em men en nt t th than an n th he he o o ov ve vera rall ll ll a a agr gr g e e eem me men n nt fr rom om om o o our ur u s sam am ampl ple e o of f r ri is sk sk c cal a cu u ula lato to tors rs rs. Funding Sources: The project is funded by a grant from the Edmonton North Primary Care
Network. The funder had not involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. by guest on April 14, 2017 Web Appendix: Sample Calculations
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How was the risk category spread assessed?
Our sample patient was 50-year-old male, non-diabetic smoker with a systolic blood pressure of 160, total cholesterol of 4 mmol/L, and HDL of 1.3 mmol/L. Using the three-category system of low (L) (<10%), moderate (M) (10 to<20%), and high (H) (≥20% 
